International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting (May 17-20, 2021 - Virtual Meeting)
Copyright 2021 Clarivate Analytics..
COVID-19 has pushed us to think differently about health and its delivery, and following the declaration of pandemic by the World Health Organization (WHO), value chains have been largely broken and must be rebuilt and redesigned. COVID-19 brought the whole world to a standstill, and its impact on overall healthcare utilization and cost trends is undeniable; as such, the importance of public health expertise and health economics outcomes research (HEOR) to support and inform public health cannot be overstated. The virtual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting brought together experts and leaders in the HEOR field to explore topics that will shape healthcare decision making over the coming decades and to consider the useful lessons learnt from COVID-19 and how these will impact healthcare decisions in the post-COVID-19 era.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
Drugs of today (Barcelona, Spain : 1998) - 57(2021), 8 vom: 13. Aug., Seite 519-525 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kibble, A [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 19.08.2021 Date Revised 19.08.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1358/dot.2021.57.8.3339712 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32948785X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32948785X | ||
| 003 | DE-627 | ||
| 005 | 20231225205227.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1358/dot.2021.57.8.3339712 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1098.xml |
| 035 | |a (DE-627)NLM32948785X | ||
| 035 | |a (NLM)34405209 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kibble, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting (May 17-20, 2021 - Virtual Meeting) |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.08.2021 | ||
| 500 | |a Date Revised 19.08.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright 2021 Clarivate Analytics. | ||
| 520 | |a COVID-19 has pushed us to think differently about health and its delivery, and following the declaration of pandemic by the World Health Organization (WHO), value chains have been largely broken and must be rebuilt and redesigned. COVID-19 brought the whole world to a standstill, and its impact on overall healthcare utilization and cost trends is undeniable; as such, the importance of public health expertise and health economics outcomes research (HEOR) to support and inform public health cannot be overstated. The virtual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting brought together experts and leaders in the HEOR field to explore topics that will shape healthcare decision making over the coming decades and to consider the useful lessons learnt from COVID-19 and how these will impact healthcare decisions in the post-COVID-19 era | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cost effectiveness | |
| 650 | 4 | |a Data mining | |
| 650 | 4 | |a Health economics outcomes research (HEOR) | |
| 650 | 4 | |a Health technology assessment (HTA) | |
| 650 | 4 | |a Healthcare use and spending | |
| 650 | 4 | |a Public health economics | |
| 650 | 4 | |a Realworld evidence | |
| 650 | 4 | |a Venture funding | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs of today (Barcelona, Spain : 1998) |d 1998 |g 57(2021), 8 vom: 13. Aug., Seite 519-525 |w (DE-627)NLM123139600 |x 1699-3993 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2021 |g number:8 |g day:13 |g month:08 |g pages:519-525 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1358/dot.2021.57.8.3339712 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2021 |e 8 |b 13 |c 08 |h 519-525 | ||